ACE2 and diabetes mellitus: Based on the identification of ACE2 as the receptor for SARS-CoV-2 entry, there is a hypothesis that the increased risk of severe COVID-19 is a function of upregulated ACE2, as is found in the co-morbidities of diabetes, cardiovascular disease and hypertension [58].